Alameda C, Lucas T, Pineda E, Brito M, Uría J G, Magallón R, Estrada J, Barceló B
Department of Endocrinology, Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid, Madrid, Spain.
J Endocrinol Invest. 2005 Jan;28(1):18-22. doi: 10.1007/BF03345524.
The indications for additional radiotherapy (RT) after surgery for non-functioning pituitary adenoma are controversial. The goal of this retrospective study was to evaluate the outcome of surgically treated patients, with or without post- operative irradiation.
Review of cases treated for non-functioning pituitary adenoma. Fifty-one patients were identified, with a mean post-operative follow-up of 6.4+/-3.5 yr. Twenty-nine patients showed residual tumor after surgery and 22 did not. Serial endocrine, visual and radiological evaluations were made after treatment to assess the efficacy and toxicity of surgery and RT. Twenty-seven patients with residual tumor after surgery received RT (22 of them during the post-operative period and 5 after an interval of several yr: 3 because of increased tumor size and 2 with stable residual lesion); tumors in 14 of these patients decreased in size, 11 appeared to be stable on imaging and one patient showed some increase in tumor size (one patient was not followed-up). The residual tumors of the 2 non-irradiated patients remained stable after 5 and 7 yr, respectively. Twenty-two patients without residual disease after surgery (11 with post-operative irradiation, 1 with RT 5 yr after transsphenoidal surgery because of tumor recurrence, and 10 without RT) have shown no evidence of tumor regrowth on serial images.
Radiotherapy can be avoided in patients with complete macroscopic resection and absence of residual tumor in post-operative images; they must be carefully followed using imaging techniques and, in the case of recurrence, they should be re-operated and/or irradiated.
无功能垂体腺瘤术后辅助放疗(RT)的适应证存在争议。本回顾性研究的目的是评估手术治疗患者(无论是否接受术后放疗)的结局。
回顾无功能垂体腺瘤的治疗病例。共纳入51例患者,术后平均随访6.4±3.5年。29例患者术后有残留肿瘤,22例无残留。治疗后进行系列内分泌、视力和影像学评估,以评估手术和放疗的疗效及毒性。27例术后有残留肿瘤的患者接受了放疗(其中22例在术后期间接受放疗,5例在数年间隔后接受放疗:3例因肿瘤增大,2例残留病灶稳定);这些患者中有14例肿瘤缩小,11例影像学表现稳定,1例患者肿瘤增大(1例患者未随访)。2例未接受放疗的患者残留肿瘤分别在5年和7年后保持稳定。22例术后无残留疾病的患者(11例接受术后放疗,1例经蝶窦手术后5年因肿瘤复发接受放疗,10例未接受放疗)系列影像检查未显示肿瘤复发迹象。
术后影像显示肿瘤完全切除且无残留的患者可避免放疗;必须使用影像学技术对其进行密切随访,如复发,应再次手术和/或放疗。